Anti-IFNL4 antibody [51-1]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal IFNL4 antibody. Suitable for BL, WB and reacts with Human, Synthetic peptide samples. Cited in 9 publications.
View Alternative Names
Interferon lambda-4, IFN-lambda-4, IFNL4
- BL
Supplier Data
Blocking - Anti-IFNL4 antibody [51-1] (AB196984)
Stable inducible HepG2-IFN-λ4-ISRE-Luc cells were induced with 0.5 mg/ml doxycycline for 16hours and then treated with PBS (negative control) and rabbit IgG (20μg/ml) for 22 hours and assayed for luciferase expression. α-IFN-λ4 (ab196984) blocks the ability of IFN-λ4 to induce of ISRE-Luc reporter by 70%.
This image was generated from the hybridoma version of the product.
This image is courtesy of Ludmila Prokunina-Olsson
- WB
Supplier Data
Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
Prokunina-Olsson, NG, 2013 and Onabajo et al, JICR, 2015
This image was generated from the hybridoma version of the product.
All lanes:
Western blot - Anti-IFNL4 antibody [51-1] (ab196984) at 1/1500 dilution
Lane 1:
Recombinant Interferon lambda 4 protein (250 ng)
Lane 2:
Recombinant Interferon lambda 4 protein (50 ng)
Predicted band size: 20 kDa
false
This image is courtesy of Ludmila Prokunina-Olsson
- WB
Unknown
Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
Blocking and dilution buffer : 5% NFDM/TBST.
The observed size is larger (50 kDa for IFNL4-Halo than the predicted size because of the Halo-tag.
All lanes:
Western blot - Anti-IFNL4 antibody [51-1] (ab196984) at 1/1000 dilution
Lane 1:
Empty vector transfected HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 2:
HepG2 transfected with Halo-tagged IFNL4, whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 20 kDa
false
- WB
CiteAb
Western blot - Anti-IFNL4 antibody [51-1] (AB196984)
IFNL4 western blot using anti-IFNL4 antibody [51-1] ab196984. Publication image and figure legend from Sung, P. S., Hong, S. H., et al., 2017, Sci Rep, PubMed 28630501.
ab196984 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab196984 please see the product overview.
IFN-λ4 overexpression induces ISG expression. (A,B) Huh-7 cells were transfected with control or IFN-λ4-expressing plasmids. After 72 hours, the cell lysates (A) and culture supernatants (B) were harvested, and protein expression were analysed by immunoblot. For the culture supernatants, immunoprecipitation with anti-FLAG-conjugated beads were used to pull down the FLAG-tagged IFN-λ4 protein. The data are representative of two independent experiments. (C,D) Huh-7 cells were transfected with control, IFN-λ1-, IFN-λ4-, or IFN-β-expressing plasmids. After 96 hours, the cells were harvested, and protein expression or gene expression were analysed by immunoblot (C) or real-time qPCR (D). (E) Huh-7 cells were transfected with IFN-λ4-expressing plasmids. The cells were harvested at the indicated time points, and gene expression was analysed by real-time qPCR. (F) Huh-7 cells were infected with JFH1 HCVcc at 0.5 MOI followed by transfection with control or IFN-λ4-expressing plasmids. After 72 hours, the cells were harvested, and HCV RNA titer was analysed by real-time qPCR. (G,H) Huh-7 cells were transfected with control, IFN-λ4-, or IFN-λ4 TT-encoding plasmids. After 96 hours, the cells were harvested, and protein and gene expression were analysed by immunoblot (G) or real-time qPCR (H). In (D,E,F,H) data are presented as means ± S.E.M. ***P ≤ 0.001 (Student’s t-test). All the data are representative of two independent experiments. Full-length blots of PY-STAT1 (C) with multiple exposure times are included in the Supplementary Fig. 9C.
false
Related conjugates and formulations (1)
-
Anti-IFNL4 antibody [51-1] - BSA and Azide free
Reactivity data
Product details
This product has switched from a hybridoma to recombinant production method on 6th January 2021.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IFNL4 acts as a cytokine and contributes to modulating immune responses. It is not part of a complex but interacts closely with the IFN lambda receptor to activate Janus kinase and signal transducer and activator of transcription (JAK-STAT) signaling pathways. This activation leads to the promotion of antiviral responses in infected cells and limits viral spread. Understanding its signaling function clarifies its important impact on immune defense.
Pathways
IFNL4 is fundamental to the JAK-STAT signaling pathway and to the innate immune response pathway. These pathways mediate cellular responses to viral infections. IFNL4 interacts with other proteins like IFNLR1 IL10RB and STAT1 which are essential for these pathways. By engaging these pathways IFNL4 helps control the expression of genes involved in antiviral defense such as those coding for interferon-stimulated genes (ISGs).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 12:692263 PubMed34497603
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cytokine 125:154833 PubMed31479875
2019
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 1:191 PubMed30456312
2018
Applications
WB
Species
Human
Clinical cancer research : an official journal of 24:5471-5481 PubMed30012562
2018
Applications
BL
Species
Human
Journal of immunology (Baltimore, Md. : 1950) 199:3808-3820 PubMed29070670
2017
Applications
WB
Species
Human
Scientific reports 7:3821 PubMed28630501
2017
Applications
WB
Species
Human
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 36:30-6 PubMed26308395
2015
Applications
WB
Species
Human
Journal of interferon & cytokine research : the of 35:888-900 PubMed26134097
2015
Applications
BL, WB
Species
Human, Human
Nature genetics 45:164-71 PubMed23291588
2013
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com